Results 91 to 100 of about 33,332 (299)

Frontrunner in Translation: Progressive Supranuclear Palsy

open access: yesFrontiers in Neurology, 2019
Progressive supranuclear palsy (PSP) is a four-repeat tau proteinopathy. Abnormal tau deposition is not unique for PSP and is the basic pathologic finding in some other neurodegenerative disorders such as Alzheimer's disease (AD), age-related tauopathy ...
Ali Shoeibi, Nahid Olfati, Irene Litvan
doaj   +1 more source

PET-CT imaging in a patient with progressive supranuclear palsy [PDF]

open access: yes, 2015
Hosp Beneficencia Portuguesa São Paulo, Med Imagem, BR-01323001 São Paulo, SP, BrazilUniversidade Federal de São Paulo, Dept Neurol, São Paulo, SP, BrazilHosp Coracao, São Paulo, SP, BrazilUniversidade Federal de São Paulo, Dept Neurol, São Paulo, SP ...
Amaral, Lazaro Luiz Faria do   +6 more
core   +2 more sources

Comparison of Two α‐Synuclein Seed Amplification Assays for Discrimination of Parkinson Disease and Atypical Parkinsonism

open access: yesMovement Disorders, EarlyView.
Abstract Background Seed amplification assays (SAAs) for misfolded α‐synuclein (syn) have shown inconsistent results in multiple system atrophy (MSA). Objective The objective of this study was to compare a novel syn SAA (synSAA) that distinguishes between Lewy body disease (LBD) and MSA syn‐seeds (Amprion‐SAA) with an LBD‐specific synSAA (IRCCS ...
Marcello Rossi   +10 more
wiley   +1 more source

Multireceptor fingerprints in progressive supranuclear palsy

open access: yesAlzheimer’s Research & Therapy, 2017
Background Progressive supranuclear palsy (PSP) with a frontal presentation, characterized by cognitive deficits and behavioral changes, has been recognized as an early clinical picture, distinct from the classical so-called Richardson and parkinsonism ...
Wang Zheng Chiu   +7 more
doaj   +1 more source

Rapidly progressive atypical parkinsonism associated with frontotemporal lobar degeneration and motor neuron disease [PDF]

open access: yes, 2010
Objective To report the rare but distinct clinical and neuropathological phenotype of non-familial, rapidly progressive parkinsonism and dementia associated with frontotemporal lobar degeneration with motor neuron disease (FTLD-MND).
de Courten-Myers, Gabrielle M.   +6 more
core   +1 more source

Reply to “Neurophysiological Testing to Diagnose Stiff‐Person Spectrum Disorder”

open access: yes
Movement Disorders Clinical Practice, EarlyView.
João Moura   +5 more
wiley   +1 more source

Brain Atrophy Does Not Predict Clinical Progression in Progressive Supranuclear Palsy

open access: yesMovement Disorders, EarlyView.
Abstract Background Clinical progression rate is the typical primary endpoint measure in progressive supranuclear palsy (PSP) clinical trials. Objectives This longitudinal multicohort study investigated whether baseline clinical severity and regional brain atrophy could predict clinical progression in PSP–Richardson's syndrome (PSP‐RS).
Andrea Quattrone   +424 more
wiley   +1 more source

Diagnostic challenges in multiple system atrophy

open access: yesNeuropsychiatric Disease and Treatment, 2018
Diana Obelieniene,1 Sandra Bauzaite,1 Ilona Kulakiene,2 Evaldas Keleras,2 Indre Eitmonaite,3 Daiva Rastenyte1 1Department of Neurology, 2Department of Radiology, 3Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania Abstract ...
Obelieniene D   +5 more
doaj  

Early-stage [123I]beta-CIT SPECT and long-term clinical follow-up in patients with an initial diagnosis of Parkinson's disease [PDF]

open access: yes, 2005
beta-CIT binding in both caudate nuclei was lower than in the group of patients with IPD. In addition, putamen to caudate binding ratios were higher in the group of APS patients.
A Antonini   +39 more
core   +1 more source

Immunotherapy in progressive supranuclear palsy

open access: yesCurrent Opinion in Neurology, 2020
Purpose of review Progressive supranuclear palsy (PSP) is a progressive adult-onset neurodegenerative disease. Abnormally, phosphorylated forms of the microtubule-associated protein tau containing four repeat domains (4R-tau) aggregate in neurons. Additionally, increasing evidence suggests that secretion and uptake of fragments
Pavan A. Vaswani, Abby L. Olsen
openaire   +4 more sources

Home - About - Disclaimer - Privacy